Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Arch Orthop Trauma Surg ; 143(4): 2175-2180, 2023 Apr.
Article in English | MEDLINE | ID: mdl-35488919

ABSTRACT

INTRODUCTION: One of the most important challenges faced by orthopedic surgeons is periprosthetic joint infection (PJI). PJI is a common cause for total joint arthroplasty failure with an incidence of 0.3-1.9%. PJI can be devastating for the patient and extremely costly for the healthcare system. There is concern that a major cause of PJI is intra-operative colonization and recent studies have shown a decrease in PJI with the use of dilute povidone-iodine (Betadine®, Avrio Health L.P, Stamford, CT) irrigation prior to wound closure. This study presents our experience with the use of dilute Betadine® irrigation prior to wound closure and its effect on our post-operative hip and knee arthroplasty acute infection rate. MATERIALS AND METHODS: Retrospective chart review performed at our hospital looking at PJI amongst patients who underwent primary total hip arthroplasty (THA) or total knee arthroplasty (TKA) between 2013 and 2017 comparing different irrigation methods (n = 3232). The study group (n = 1207) underwent irrigation prior to wound closure with dilute Betadine for 3 min and the control group (n = 1511) underwent irrigation using normal saline (NS). RESULTS: Using a logistic regression model where the following variables were adjusted for; ASA, age, sex, foley insertion, surgical duration and diabetes mellitus status a statistical significant reduction was seen in any infection (OR 0.45 [0.22; 0.89], p value < 0.05) and SSI (OR 0.30 [0.13; 0.70], p value 0.01) with the Betadine group. No significant reduction was seen with deep infections with the Betadine group compared to the NS group. CONCLUSION: PJI is a devastating complication following total joint arthroplasty and we found Betadine compared to NS irrigation provides an inexpensive and simple method to lower any PJI and more specifically SSI in THA and TKA. LEVEL OF EVIDENCE: III.


Subject(s)
Arthritis, Infectious , Arthroplasty, Replacement, Hip , Arthroplasty, Replacement, Knee , Prosthesis-Related Infections , Humans , Povidone-Iodine/therapeutic use , Arthroplasty, Replacement, Knee/adverse effects , Retrospective Studies , Prosthesis-Related Infections/etiology , Prosthesis-Related Infections/prevention & control , Prosthesis-Related Infections/epidemiology , Arthroplasty, Replacement, Hip/adverse effects , Arthritis, Infectious/complications
2.
J Bone Joint Surg Am ; 104(3): 271-283, 2022 02 02.
Article in English | MEDLINE | ID: mdl-34878411

ABSTRACT

BACKGROUND: Torsional hip deformities are common among patients undergoing hip arthroscopy. However, recent studies have suggested conflicting outcomes following arthroscopy in the setting of abnormal hip version. The purpose of this study was to systematically evaluate the literature and determine the impact of femoral and acetabular version on patient-reported outcomes following primary arthroscopic hip surgery. METHODS: This study was conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. Studies investigating femoral and acetabular version in primary hip arthroscopy with clinical outcomes were identified, and data were extracted in duplicate. RESULTS: Overall, 11 studies met inclusion criteria and comprised 1,297 hips (726 femora and 571 acetabulae), with a mean patient age of 29.2 years (range, 14 to 74.7 years). In patients with acetabular retroversion, there was no significant difference, when compared with the normal acetabular version group, in the modified Harris hip score (mHHS), the Hip Outcome Score-Sports Specific Subscale (HOS-SSS), and visual analog scale (VAS) pain scores postoperatively. Among patients with femoral retroversion, in 2 of 3 studies, the authors reported no difference in mHHS postoperatively compared with patients with normal femoral version. In patients with high femoral anteversion, in 2 of 3 studies, the authors reported a significant difference in postoperative mHHS favoring patients with normal femoral version. Studies examining high femoral anteversion included patients with borderline hip dysplasia and patients who underwent concurrent psoas-lengthening procedures. CONCLUSIONS: Although the definition of the normal version of the hip varied within the literature, hip arthroscopy in patients with acetabular retroversion resulted in no difference in functional outcomes compared with patients with normal version. Postoperative functional outcomes in patients with femoral retroversion and high femoral anteversion were mixed, although the procedure was possibly less effective in high femoral anteversion combined with specific clinical scenarios. Further prospective studies based on standardized definitions and version analysis techniques would be useful in identifying the precise surgical indications for safe arthroscopic surgical procedures in patients with version abnormalities of the femur and acetabulum, particularly those with high femoral anteversion and retroversion. LEVEL OF EVIDENCE: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.


Subject(s)
Acetabulum/surgery , Arthroplasty, Replacement, Hip/methods , Femur/surgery , Hip Joint/surgery , Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Treatment Outcome , Young Adult
4.
JBJS Case Connect ; 10(2): e0493, 2020.
Article in English | MEDLINE | ID: mdl-32649103

ABSTRACT

CASE: A 59-year-old man presented with a history of a painful, rapidly growing mass on the anteromedial aspect of his thigh. On examination, he had a mobile, hard, and nontender mass. Magnetic resonance imaging revealed a well-encapsulated, heterogeneous mass with high-intensity internal septations. Blood-filled spaces were observed within the mass with no involvement of the underlying normal bony structures. The mass was excised, and the diagnosis of an extraosseous aneurysmal bone cyst was confirmed histologically. CONCLUSIONS: Extraosseous aneurysmal bone cysts are rare benign lesions that can mimic malignant tumors. Careful clinical and pathological assessment should be performed in such cases.


Subject(s)
Bone Cysts, Aneurysmal/diagnostic imaging , Bone Cysts, Aneurysmal/pathology , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Radiography , Thigh/pathology
5.
JBJS Case Connect ; 10(1): e0506, 2020.
Article in English | MEDLINE | ID: mdl-32044792

ABSTRACT

CASE: We report a 27-year-old man who presented with thigh swelling and inability to bear weight after blunt trauma 24 hours before. Based on the clinical assessment, the patient was diagnosed with anterior compartment syndrome of the thigh and underwent fasciotomy. Postoperatively, 1.5 L of blood were drained from his wound in the first 30 minutes after the operation. Angiography was performed demonstrating bleeding from the lateral femoral circumflex which was successfully embolized. CONCLUSIONS: Our case represents the underlying arterial injury that was initially undiagnosed as a cause for thigh compartment syndrome. Physicians should consider associated injuries (beyond muscle crush) when making a diagnosis of compartment syndrome.


Subject(s)
Compartment Syndromes/etiology , Thigh/injuries , Vascular System Injuries/complications , Wounds, Nonpenetrating/complications , Adult , Compartment Syndromes/surgery , Fasciotomy , Humans , Male , Thigh/surgery
6.
Skin Appendage Disord ; 5(5): 304-308, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31559255

ABSTRACT

Dermatophytomas represent a historically difficult-to-treat complication of onychomycosis and are characterized by adherent fungal masses encased in biofilm in the subungual space. In this study, we evaluated the efficacy of 10% efinaconazole solution in patients with onychomycosis complicated by dermatophytomas. Cure was achieved in 65% of target great toenails. All dermatophytomas resolved and did not recur during the study. The median time to dermatophytoma resolution was 16 weeks.

7.
J Card Surg ; 34(6): 412-418, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30995341

ABSTRACT

INTRODUCTION: Few bioprosthetic valved conduits for aortic root surgery are commercially available. Long-term Warfarin therapy (mechanical), potential root calcification (xeno- or homograft valves), and the need for additional ascending aorta grafts are concerns associated with currently used valved conduits. A simplified, self-assembled bioroot conduit comprising currently available materials that facilitates future intervention and exhibits advantages of a bioprosthesis was used. METHODS: From November 2015 to January 2017, 17 consecutive patients underwent urgent or elective aortic root surgery. A bioroot conduit, constructed using 28 or 30 mm of sinus of Valsalva Gelweave tube graft and a 3 to 5 mm smaller bioprosthetic Trifecta valve sewn into the sinus of Valsalva base, was preconstructed in the operating room before sternotomy. The size of the valved conduit was based on the distal ascending aorta or proximal arch and not aortic annular dimension. The bioroot was sutured to the native aortic annulus at the level of the bottom skirt of the Valsalva graft without contacting the sewing cuff of the bioprosthetic valve. RESULTS: All patients survived the operation and were discharged home without long-term anticoagulation therapy. The mean age was 65 ± 12 years, and 13 patients were male. The cardiopulmonary bypass duration was 169 ± 84 minutes, and the cross-clamp (XC) duration was 110 ± 32 minutes. The operation was elective in 12 patients, urgent/emergent in five, and redo in three. CONCLUSION: A simplified self-assembled bioroot Bentall conduit is appropriate for aortic root reconstruction. Use of a patient-tailored valved conduit will not prolong the cardiac ischemic time and will facilitate future valve replacement.


Subject(s)
Aorta/surgery , Aortic Valve/surgery , Bioprosthesis , Blood Vessel Prosthesis Implantation/methods , Heart Valve Prosthesis Implantation/methods , Sinus of Valsalva/surgery , Adult , Aged , Elective Surgical Procedures , Female , Humans , Male , Middle Aged
8.
JBJS Rev ; 7(4): e8, 2019 04.
Article in English | MEDLINE | ID: mdl-31021893

ABSTRACT

BACKGROUND: Lipoma arborescens is a rare, intra-articular benign lesion characterized by hyperplastic formation of villous projections that commonly presents as nonspecific mechanical knee pain. The treatment of choice for lipoma arborescens of the knee is open or arthroscopic synovectomy. However, data are lacking on the success of arthroscopic treatment, despite its increasingly widespread use. We aimed to systemically review the outcomes of arthroscopic treatment of lipoma arborescens. METHODS: PubMed and Embase were searched by 2 reviewers independently on October 9, 2018, and all relevant articles in the English and French languages up to and including that date were considered. The search terms "lipoma arborescens," "knee," "arthroscopy," and "arthroscopic" were used. Articles were screened on the basis of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. RESULTS: Among the 110 initial studies that were retrieved, 28 satisfied the inclusion criteria. A total of 71 knees in 65 patients ranging from 13 to 78 years of age underwent arthroscopic synovectomy for the treatment of lipoma arborescens. The duration of follow-up ranged from 3 weeks to 84 months. The recurrence rate was 2.8%, and 2 patients underwent conversion to open surgery. One patient had postoperative hematoma that required evacuation, and another patient reported persistent residual pain at the time of the latest follow-up. CONCLUSIONS: On the basis of this uncontrolled, systematic review, arthroscopic synovectomy is a safe and effective treatment for lipoma arborescens of the knee, with a success rate of >95%. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.


Subject(s)
Arthroscopy , Joint Diseases/surgery , Knee Joint/surgery , Lipoma/surgery , Synovectomy , Humans , Joint Diseases/pathology , Knee Joint/pathology , Lipoma/pathology , Synovial Membrane/pathology , Treatment Outcome
9.
Skin Appendage Disord ; 5(1): 9-12, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30643774

ABSTRACT

BACKGROUND: Topical efinaconazole 10% solution is a promising new treatment for distal lateral subungual onychomycosis (DLSO). However, it is unknown whether this treatment is both compatible and efficacious in individuals wearing toenail polish. MATERIALS AND METHODS: We evaluated the efficacy and compatibility of efinaconazole 10% solution with concurrent nail polish use in treating DLSO over 52 weeks. Efficacy was assessed using the onychomycosis severity index (OSI) and by measuring nail growth and thickness, while compatibility with nail polish was evaluated with questionnaires. RESULTS: Eleven patients completed the study; 6 wore nail polish regularly and 5 abstained from polish. The efficacy of efinaconazole was not diminished by concurrent nail polish use as measured by OSI, nail growth, and thickness. However, this treatment produced undesirable cosmetic changes to the quality of nail polish over time. CONCLUSIONS: While efinaconazole 10% solution is an effective treatment of DLSO in patients wearing nail polish, this treatment may diminish the quality of the polish. Further research and development is needed to enhance the compatibility of topical onychomycosis treatments with nail polish use.

10.
Arch Dermatol Res ; 309(6): 453-459, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28516243

ABSTRACT

Folliculotropic mycosis fungoides (FMF) is a distinct variant of mycosis fungoides (MF) where atypical T-cells invade the hair follicles. The objective was to assess the clinical features, risk factors for progression, long-term outcome and response to treatment modalities in a large cohort of FMF patients. We, therefore, conducted a single-center retrospective study, reviewing 114 patients with FMF seen from 1987 to 2015 at the cutaneous T-cell lymphoma clinic of the MD Anderson Cancer Center. The mean age at diagnosis of FMF was 57.1 ± 13.5 years. The male to female ratio was 1.2:1. MF stage IA (n = 50, 43.9%) was the most common diagnosed stage, followed equally by stages IB and IIB (n = 23, 20.2%, respectively). Eighty-six patients (75.4%) suffered from pruritus. Concomitant hair loss was observed in 37 (32.5%) subjects. The median number of different treatment modalities used per patient was 4 (range 1-12). Low-dose radiation was beneficial in clearing therapy refractory lesions. The overall survival was influenced by several factors, including advanced age (>65), late stages and the presence of large cell transformation (LCT). Thirty-three of 113 patients (29.2%) progressed to more advanced stages and 26 (23.0%) died, with the cause of death being MF in 11 (9.7%) subjects. In conclusion, patients with FMF have a worse overall 10-year survival rate compared with other MF variants. Several factors, including stage, advanced age and the presence of LCT impact survival. Multiple different treatment approaches may be needed to achieve a good clinical response and to prevent disease progression.


Subject(s)
Hair Follicle/pathology , Mycosis Fungoides/epidemiology , Mycosis Fungoides/pathology , Skin Neoplasms/epidemiology , Skin Neoplasms/pathology , Adult , Aged , Alopecia/epidemiology , Alopecia/pathology , Biopsy , Combined Modality Therapy , Disease Progression , Epidermis/pathology , Female , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Mycosis Fungoides/therapy , Neoplasm Staging , Palliative Care/methods , Pruritus , Radiotherapy Dosage , Retrospective Studies , Risk Factors , Skin Neoplasms/therapy , Survival Rate , Treatment Outcome , Whole-Body Irradiation
11.
Ther Adv Hematol ; 7(3): 171-4, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27247757

ABSTRACT

Mogamulizumab (KW-0761) is a humanized immunoglobulin G1 (IgG1) monoclonal antibody (mAb) that targets CC chemokine receptor 4 (CCR4). It has shown promising therapeutic potential in phase I and II clinical trials and is currently being investigated for efficacy in treating cutaneous T-cell lymphoma (CTCL). We review the mechanism of action of mogamulizumab and its role in treating CTCL. We also discuss the results of major clinical trials.

13.
J Am Acad Dermatol ; 73(6): 976-86, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26476898

ABSTRACT

BACKGROUND: Leonine facies (LF) is defined as displaying facial features similar to that of a lion with prominent convexities and furrowed creases. LF develops in a very small population of patients with cutaneous T-cell lymphoma. OBJECTIVE: We aimed to study the clinicopathologic features and overall prognosis associated with LF in patients with mycosis fungoides and Sézary syndrome. METHODS: We conducted a single-center retrospective study, reviewing 1338 patients with mycosis fungoides seen from 1987 to 2015 at a tertiary referral center for cutaneous T-cell lymphoma, and a systematic review of 14 patients in the literature. RESULTS: We identified 10 patients with mycosis fungoides who developed LF. Folliculotropism was seen in all patients with LF who had facial biopsy specimens. Radiation was a beneficial therapy. Complete remission was achieved in 1 patient and overall 5-year survival was 26%. Systematic review of 10 additional patients showed that all patients with LF, including ours, had stage-IV disease and some degree of blood involvement, but not all met criteria for Sézary syndrome. LIMITATIONS: This was a retrospective study with a small sample size. CONCLUSION: LF is associated with stage-IV cutaneous T-cell lymphoma, is often accompanied by folliculotropism and blood involvement, and can be treated with local electron beam therapy.


Subject(s)
Facies , Mycosis Fungoides/pathology , Skin Neoplasms/pathology , Adult , Aged , Biopsy, Needle , Cancer Care Facilities , Cohort Studies , Combined Modality Therapy , Female , Follow-Up Studies , Humans , Immunohistochemistry , Lymphoma, T-Cell, Cutaneous/diagnosis , Lymphoma, T-Cell, Cutaneous/pathology , Lymphoma, T-Cell, Cutaneous/therapy , Male , Middle Aged , Mycosis Fungoides/diagnosis , Mycosis Fungoides/therapy , Neoplasm Invasiveness/pathology , Neoplasm Staging , Positron-Emission Tomography/methods , Retrospective Studies , Risk Assessment , Skin Neoplasms/diagnosis , Skin Neoplasms/therapy , Survival Rate , Tertiary Care Centers , Treatment Outcome
14.
JAAD Case Rep ; 1(3): 150-2, 2015 May.
Article in English | MEDLINE | ID: mdl-27051714
16.
J Am Acad Dermatol ; 70(1): 108-14, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24176524

ABSTRACT

BACKGROUND: There are no validated outcome measures for postinflammatory hyperpigmentation (PIH). OBJECTIVE: We sought to determine the reliability and validity of an outcome measure for PIH after acne in patients with skin of color. METHODS: A postacne hyperpigmentation index (PAHPI) was developed. Six raters scored 21 patients with PIH twice. Reliability was determined within and between raters, whereas validity was evaluated by comparing scores with severity ranking by an independent dermatologist. The pigment intensity scores were compared with the melanin index of each patient using a narrowband reflectance spectrophotometer. A quality-of-life score (Skindex-29) was also compared with PAHPI scores. RESULTS: Total PAHPI scores showed good reliability within and between raters and were valid when compared with clinical severity and melanin indices. Good correlation was achieved between the total PAHPI score and the emotion subscale of the Skindex-29. LIMITATIONS: Generalizability of results is limited to African American females. CONCLUSION: The PAHPI shows good reliability and validity when scored on patients with PIH from acne vulgaris. The PAHPI also correlates well with the emotional impact of PIH as measured by the Skindex-29. Future studies should assess the ability of the PAHPI to change with improvement of PIH from acne after treatment.


Subject(s)
Acne Vulgaris/complications , Hyperpigmentation/etiology , Hyperpigmentation/pathology , Severity of Illness Index , Acne Vulgaris/pathology , Adolescent , Adult , Black or African American , Asian People , Dermatitis/pathology , Female , Hispanic or Latino , Humans , Hyperpigmentation/psychology , Male , Melanins/analysis , Observer Variation , Quality of Life , Reproducibility of Results , Spectrophotometry , Young Adult
17.
Pediatrics ; 123(3): 865-9, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19255015

ABSTRACT

OBJECTIVES: The delivery of adequate but not excessive ventilation remains one of the most common problems encountered during neonatal resuscitation, especially in the very low birth weight infant. Our observations suggest that airway obstruction is a common occurrence after delivery of such infants, and we use colorimetric carbon dioxide detectors during bag-and-mask resuscitation to assist in determining whether the airway was patent. We reviewed our experience to determine the frequency of the occurrence of recognizable airway obstruction during resuscitation of very low birth weight infants. METHODS AND PATIENTS: The previous prospective trial randomly assigned preterm infants <32 weeks' gestation to resuscitation with either room air or 100% oxygen using pulse oximetry. Colorimetric carbon dioxide detectors were used to assist with bag-and-mask ventilation and to confirm intubation. From the video recordings, the number of positive pressure breaths without a color change in the detector until the breaths were associated with an unequivocal color change was counted as obstructed breaths. From the analog tracings, the number of breaths that had a peak pressure plateau of >/=0.2 second and were not associated with a color change was recorded as the number of obstructed breaths. RESULTS: None of the studied infants required cardiopulmonary resuscitation or received epinephrine, and all were judged to have an effective circulation during resuscitation. Six of the 24 infants enrolled in the trial received only continuous positive airway pressure. The remaining 18 infants received a median of 14 obstructed breaths (range: 4-37 breaths) delivered over a mean and median interval of 56.7 and 45.0 seconds, respectively (range: 10.0-220.0 seconds). A subgroup of 11 infants was analyzed using airway-pressure data. The target peak inspiratory pressure was 30 cm H(2)O. Ten of these 11 infants had obstructed breaths as defined by no change in the PediCap despite reaching the target pressure for >/=0.2 second. CONCLUSION: Airway obstruction occurs in the majority of the very low birth weight infants who receive ventilation with a face mask during resuscitation and the use of a colorimetric detector can facilitate its recognition and management.


Subject(s)
Airway Obstruction/diagnosis , Blood Gas Monitoring, Transcutaneous/instrumentation , Carbon Dioxide/blood , Colorimetry/instrumentation , Infant, Extremely Low Birth Weight , Infant, Very Low Birth Weight , Masks , Oxygen Inhalation Therapy/instrumentation , Positive-Pressure Respiration/instrumentation , Respiratory Distress Syndrome, Newborn/therapy , Resuscitation/instrumentation , Airway Obstruction/blood , Airway Obstruction/therapy , California , Female , Humans , Infant, Newborn , Intensive Care Units, Neonatal , Male , Monitoring, Physiologic/instrumentation , Prospective Studies , Randomized Controlled Trials as Topic , Respiratory Distress Syndrome, Newborn/blood , Signal Processing, Computer-Assisted/instrumentation , Treatment Outcome
18.
Pediatrics ; 121(6): 1083-9, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18519476

ABSTRACT

OBJECTIVE: In this study of preterm neonates of <32 weeks, we prospectively compared the use of room air versus 100% oxygen as the initial resuscitation gas. METHODS: A 2-center, prospective, randomized, controlled trial of neonates with gestational ages of 23 to 32 weeks who required resuscitation was performed. The oxygen group was initially resuscitated with 100% oxygen, with decreases in the fraction of inspired oxygen after 5 minutes of life if pulse oxygen saturation was >95%. The room air group was initially resuscitated with 21% oxygen, which was increased to 100% oxygen if compressions were performed or if the heart rate was <100 beats per minute at 2 minutes of life. Oxygen was increased in 25% increments if pulse oxygen saturation was <70% at 3 minutes of life or <80% at 5 minutes of life. RESULTS: Twenty-three infants in the oxygen group (mean gestational age: 27.6 weeks; range: 24-31 weeks; mean birth weight: 1013 g; range: 495-2309 g) and 18 in the room air group (mean gestational age: 28 weeks; range: 25-31 weeks; mean birth weight: 1091 g; range: 555-1840 g) were evaluated. Every resuscitated patient in the room air group met rescue criteria and received an increase in the fraction of inspired oxygen by 3 minutes of life, 6 patients directly to 100% and 12 with incremental increases. Pulse oxygen saturation was significantly lower in the room air group from 2 to 10 minutes (pulse oxygen saturation at 3 minutes: 55% in the room air group vs 87% in the oxygen group). Heart rates did not differ between groups in the first 10 minutes of life, and there were no differences in secondary outcomes. CONCLUSIONS: Resuscitation with room air failed to achieve our target oxygen saturation by 3 minutes of life, and we recommend that it not be used for preterm neonates.


Subject(s)
Air , Infant, Premature , Oxygen Inhalation Therapy , Oxygen/administration & dosage , Resuscitation/methods , Female , Humans , Infant, Newborn , Male , Oxygen/therapeutic use , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL